Acticor Biotech (France) Price on November 29, 2024
| ALACT Stock | EUR 0.29 0.02 7.41% |
If you're considering investing in Acticor Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acticor Biotech stands at 0.29, as last reported on the 4th of December, with the highest price reaching 0.30 and the lowest price hitting 0.28 during the day. Acticor Biotech appears to be out of control, given 3 months investment horizon. Acticor Biotech SAS secures Sharpe Ratio (or Efficiency) of 0.0327, which signifies that the company had a 0.0327% return per unit of risk over the last 3 months. By analyzing Acticor Biotech's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please makes use of Acticor Biotech's Risk Adjusted Performance of 0.0341, downside deviation of 12.6, and Mean Deviation of 9.85 to double-check if our risk estimates are consistent with your expectations.
Acticor Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acticor |
Sharpe Ratio = 0.0327
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALACT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.69 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Acticor Biotech is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acticor Biotech by adding it to a well-diversified portfolio.
Acticor Biotech Valuation on November 29, 2024
It is possible to determine the worth of Acticor Biotech on a given historical date. On November 29, 2024 Acticor was worth 0.26 at the beginning of the trading date compared to the closed value of 0.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acticor Biotech stock. Still, in general, we apply an absolute valuation method to find Acticor Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acticor Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acticor Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 0.28 | 0.30 | 0.27 | 0.27 | 11,980 | |
11/29/2024 | 0.26 | 0.29 | 0.26 | 0.29 | 10,914 |
| 0.29 | 0.30 | 0.28 | 0.29 | 3,167 |
| Backtest Acticor Biotech | | | Acticor Biotech History | | | Acticor Biotech Valuation | Previous | Next |
Acticor Biotech Trading Date Momentum on November 29, 2024
| On December 02 2024 Acticor Biotech SAS was traded for 0.29 at the closing time. The highest price during the trading period was 0.30 and the lowest recorded bid was listed for 0.28 . The volume for the day was 3.2 K. This history from December 2, 2024 did not affect price variability. The overall trading delta to the current price is 0.00% . |
Acticor Biotech SAS Fundamentals Correlations and Trends
By evaluating Acticor Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acticor Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acticor financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Acticor Biotech Stock history
Acticor Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acticor is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acticor Biotech SAS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acticor Biotech stock prices may prove useful in developing a viable investing in Acticor Biotech
Acticor Biotech SAS, a clinical stage biopharmaceutical company, develops drugs for the treatment of acute phase of thrombotic diseases. The company was founded in 2013 and is headquartered in Paris, France. ACTIPLAY is traded on Paris Stock Exchange in France.
Acticor Biotech Stock Technical Analysis
Acticor Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Acticor Biotech Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Acticor Biotech SAS cannot be verified against its exchange. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Acticor Biotech December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Acticor Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acticor Biotech shares will generate the highest return on investment. By undertsting and applying Acticor Biotech stock market strength indicators, traders can identify Acticor Biotech SAS entry and exit signals to maximize returns
Acticor Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acticor Biotech's price direction in advance. Along with the technical and fundamental analysis of Acticor Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acticor to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0341 | |||
| Jensen Alpha | 0.5128 | |||
| Total Risk Alpha | (1.60) | |||
| Sortino Ratio | 0.0305 | |||
| Treynor Ratio | (2.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Acticor Stock Analysis
When running Acticor Biotech's price analysis, check to measure Acticor Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acticor Biotech is operating at the current time. Most of Acticor Biotech's value examination focuses on studying past and present price action to predict the probability of Acticor Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acticor Biotech's price. Additionally, you may evaluate how the addition of Acticor Biotech to your portfolios can decrease your overall portfolio volatility.